生物技术进展 ›› 2026, Vol. 16 ›› Issue (2): 318-326.DOI: 10.19586/j.2095-2341.2025.0183

• 进展评述 • 上一篇    

肝细胞癌中的线粒体改变及其靶向治疗研究进展

韩雪奇1(), 高佩娴1, 张旭娟2, 赵鹏翔1, 刘梦昱1()   

  1. 1.北京工业大学化学与生命科学学院,北京 100124
    2.北京工业大学材料科学与工程学院,北京 100124
  • 收稿日期:2025-12-17 接受日期:2026-01-26 出版日期:2026-03-25 发布日期:2026-04-27
  • 通讯作者: 刘梦昱
  • 作者简介:韩雪奇 E-mail: hanxueqi17@163.com

Mitochondrial Alterations in Hepatocellular Carcinoma and Advances in Targeted Therapeutics

Xueqi HAN1(), Peixian GAO1, Xujuan ZHANG2, Pengxiang ZHAO1, Mengyu LIU1()   

  1. 1.College of Chemistry and Life Sciences,Beijing University of Technology,Beijing 100124,China
    2.College of Materials Science and Engineering,Beijing University of Technology,Beijing 100124,China
  • Received:2025-12-17 Accepted:2026-01-26 Online:2026-03-25 Published:2026-04-27
  • Contact: Mengyu LIU

摘要:

肝细胞癌(hepatocellular carcinoma,HCC)是全球范围内高发病率与死亡率的恶性肿瘤,其发生发展与代谢异常密切相关。线粒体作为细胞的能量代谢中心和信号枢纽,在肝细胞癌中经历复杂且多样的改变与重塑,深刻影响着肿瘤的起始、进展及治疗应答。然而,线粒体发生改变的具体机制及其在肝细胞癌中的作用尚未完全阐明,这在一定程度上阻碍了以线粒体为靶点的肝细胞癌治疗药物的研发与应用。从代谢重编程、氧化应激与线粒体DNA损伤以及线粒体动力学失调三个方面,系统总结了肝细胞癌中的线粒体改变,以及线粒体的改变在肝细胞癌发生发展和治疗应答中的作用机制,并对当前靶向线粒体的肝细胞癌治疗的相关研究进行了梳理与展望,以期为后续治疗肝细胞癌的基础研究与临床干预提供理论依据和新的思路。

关键词: 肝细胞癌, 线粒体, 线粒体动力学, 靶向治疗

Abstract:

Hepatocellular carcinoma (HCC) is a malignancy associated with high global incidence and mortality rates, whose development and progression are closely linked to metabolic dysregulation. As central hubs for cellular energy metabolism and signaling, mitochondria undergo extensive and complex remodeling in HCC, profoundly influencing tumor initiation, progression, and therapeutic response. However, the specific mechanisms underlying these mitochondrial changes and their exact roles in HCC pathogenesis remain incompletely elucidated, which has, to a certain extent, impeded the development and clinical application of mitochondria-targeted therapeutics for HCC. This review systematically summarized mitochondrial alterations in HCC from three key dimensions: metabolic reprogramming, oxidative stress and mitochondrial DNA (mtDNA) damage, and dysregulation of mitochondrial dynamics. It further elucidated the mechanisms by which these alterations drive HCC development and treatment response. Additionally, the review consolidated and prospected the current progress on mitochondria-targeted therapeutic strategies for HCC, aiming provide theoretical foundation and novel insights for future basic research and clinical interventions in the treatment of HCC.

Key words: hepatocellular carcinoma, mitochondria, mitochondrial dynamics, targeted therapeatics

中图分类号: